Reliability of cardiac magnetic resonance imaging indicators of myocardial viability for predicting the recovery of systolic function after a first acute myocardial infarction with a patent culprit artery;Fiabilidad de los índices de viabilidad miocárdica por resonancia magnética para predecir la mejoría de la función sistólica en pacientes con un primer infarto reciente y arteria abierta

Revista Espanola de Cardiologia

Volumn 57, Issue 9, 2004, Pages 826-833

  López Lereu, María P ^a   Bodí, Vicente ^a   Sanchis, Juan ^a   García, Diego ^a   Pellicer, Mauricio ^a   Losada, Antonio ^a   Chorro, Francisco J ^a   Estornell, Jordi ^a   Igual, Begoña ^a   Maceira, Alicia ^a   Martín, Joaquín ^a   Llàcer, Ángel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Acute myocardial infarction; Cardiac magnetic resonance; Delayed enhancement; Myocardial viability

Indexed keywords

DOBUTAMINE; GADOLINIUM PENTETATE MEGLUMINE; MAGNOGRAF;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE VOLUME; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; SYSTOLE; VASCULAR PATENCY;

EID: 7044222235     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(04)77202-4     Document Type: Article

References (26)

1. Borreguero LJ, Ruiz-Salmeron R. Valoración de la viabilidad miocárdica en pacientes prerrevascularización. Rev Esp Cardiol 2003;56:721-33.
2. Sandstede JJW. Assessment of myocardial viability by MR imaging. Eur Radiol 2003;13:52-61.
3. Bax JJ, De Roos A, Van der Wall EE. Assessment of myocardial viability by MRI. J Magn Res Imag 1999;10:418-22.
4. Mahrholdt H, Wagner A, Judd RM, Sechtem U. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002;23:602-19.
5. Miller S, Helber U, Brechtel K, Nägele T, Hahn U, Kramer U, et al. MR imaging at rest early after myocardial infarction: detection of preserved function in regions with evidence for ischemic injury and non-transmural myocardial infarction. Eur Radiol 2003;13:498-506.
6. Standardization of cardiac tomographic imaging. From the Committee on Advanced Cardiac Imaging and Technology, Council on Clinical Cardiology, American Heart Association; Cardiovascular Imaging Committe, American College of Cardiology; and Board of Directors, Cardiovascular Council, Society of Nuclear Medicine. Circulation 1992;86:338-9.
7. Lauerma K, Niemi P, Hänninen H, Janatuinen T, Voipio-Pulkki LM, Knuuti J, et al. Multimodality MR imaging assesment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology 2000;217:729-36.
8. Baer FM, Smolarz K, Theissen P. Regional 201Tc-methoxyisobutyl-isonotrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. Eur Heart J 1994;15:97-107.
9. Baer FM, Voth E, Scheider CA. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with (15F) fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-15.
10. Baer FM, Theissen P, Scheider CA. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8.
11. Baer M, Kenn W, Werner E, Pabst T, Lipke C, Kretschmer S, et al. Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 1999;17:1437-43.
12. 99mTc-Tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98:1869-74.
13. Bodí V, Sanchís J, López-Lereu NIP, Llácer A, Pellicer M, Losada A, et al. Estudio de la perfusión en pacientes postinfarto mediante ecografía miocárdica con inyección de contraste intracoronario. Implicaciones y relación con la angiografía y la resonancia magné tica. Rev Esp Cardiol 2004;57:20-8.
14. Wu KC, Zerhouni EA, Judd RM, Lugo OCH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
15. Kim RJ, Fieno DS, Arrish TB, Harris K, Chen EL, Simoneti O. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
16. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
17. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7.
18. Beek AM, Kühl HP, Bondarenko O, Twisk J, Hofman M, Van Dockum G, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003;42:895-901.
19. Kühl HP, Beek AM, Van der Weerdt AP, Hofman MBM, Visser FC, Van Rossum AC. Myocardial viability in chronic ischemic heart disease. J Am Coll Cardiol 2003;41:1341-8.
20. Saeed M, Lund G, Wendland MF, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellullar nonspecific contrast media. Circulation 2001;103:871-6.
21. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-42.
22. Rogers WJ, Kramer CM, Gestin G, Hu YL, Theobald TM, Vido DA, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999;99:744-50.
23. Kramer CM, Rogers WJ, Mankad S, Theobald TM, Pakstis DL, Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000;36:1835-40.
24. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JAC. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
25. Sandstede J, Lipke C, Beer M, Harre K, Pabst T, Kenn W, et al. Analysis of first-pass and delayed MRI contrast enhancement patterns of dysfunctional myocardium for the prediction of myocardial viability. AJR Am J Roentgenol 2000; 174:1737-40.
26. Van Hoe L, Vanderheyden M. Ischemic cardiomyopathy: value of the different MRI techniques for prediction of functional recovery after revascularization. Am J Radiology 2004;182:95-100.